ABRIGIM

Welcome to the Brand page for “ABRIGIM”, which is offered here for Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in haematology, in oncology in transplantation, in ophthalmology, for use in the gastroenterological areas and the prevention and treatment of ocular disorders or diseases, anti-infectives, pharmaceutical preparations treating bacterial-bases disease, antivirals, anti-biotics, antifungals, vaccines, diagnostic preparations for medical use;.

Its status is currently believed to be active. Its class is unavailable. “ABRIGIM” is believed to be currently owned by “SIGMA-TAU INDUSTRIE FARMACEUTICHE; RIUNITE S.p.A.”